Relievant Medsystems Receives 2023 Gallup Exceptional Workplace Award
30 mars 2023 09h00 HE
|
Relievant Medsystems, Inc.
MINNEAPOLIS, March 30, 2023 (GLOBE NEWSWIRE) -- Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic pain, a type of chronic low back pain (CLBP),...
Relievant Medsystems Announces Positive Local Coverage Determination by Palmetto GBA for Basivertebral Nerve Ablation in Treating Chronic Vertebrogenic Low Back Pain
06 mars 2023 08h30 HE
|
Relievant Medsystems, Inc.
MINNEAPOLIS, March 06, 2023 (GLOBE NEWSWIRE) -- Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic pain, a type of chronic low back pain (CLBP),...
Relievant Medsystems Announces Formal Coverage Recommendation from NASS for Basivertebral Nerve Ablation as a Treatment for Chronic Vertebrogenic Low Back Pain
22 févr. 2023 16h10 HE
|
Relievant Medsystems, Inc.
MINNEAPOLIS, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic pain, a type of chronic low back pain (CLBP),...
Relievant Medsystems Announces Highest Quality of Evidence Ranking for Basivertebral Nerve Ablation in ASPN Back Guideline for Interventional Low Back Pain Treatments
05 janv. 2023 16h10 HE
|
Relievant Medsystems, Inc.
MINNEAPOLIS, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic pain, a type of chronic low back pain (CLBP),...
Relievant Medsystems Announces Updated Policy Statement and Guideline for Basivertebral Nerve Ablation from the International Society for the Advancement of Spine Surgery
08 nov. 2022 16h30 HE
|
Relievant Medsystems, Inc.
MINNEAPOLIS, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic pain, a type of chronic low back pain (CLBP),...
Relievant Medsystems Receives Most Promising New Product Award for the Intracept Procedure at the 27th Annual Phoenix Conference
26 oct. 2022 16h15 HE
|
Relievant Medsystems, Inc.
MINNEAPOLIS, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Relievant Medsystems, a company focused on transforming the diagnosis and treatment of vertebrogenic pain, a type of chronic low back pain (CLBP),...
Relievant Medsystems Announces Publication of ASPN Guidelines on the Diagnosis and Treatment of Vertebrogenic Low Back Pain with Basivertebral Nerve Ablation
20 sept. 2022 09h00 HE
|
Relievant Medsystems, Inc.
MINNEAPOLIS, Sept. 20, 2022 (GLOBE NEWSWIRE) -- Relievant Medsystems, a company focused on transforming the diagnosis and treatment of vertebrogenic pain, a type of chronic low back pain (CLBP),...
NBC News’ TODAY Features the Minimally Invasive Intracept® Procedure for Chronic Vertebrogenic Low Back Pain
13 juin 2022 10h30 HE
|
Relievant Medsystems, Inc.
MINNEAPOLIS, June 13, 2022 (GLOBE NEWSWIRE) -- Relievant Medsystems shared today that the company’s breakthrough chronic low back pain treatment, the Intracept Procedure, was featured on NBC’s TODAY...
Relievant Medsystems Announces New Category I CPT Codes for Intracept® Procedure
03 janv. 2022 09h30 HE
|
Relievant Medsystems, Inc.
MINNEAPOLIS, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), announced today that new...
Relievant Medsystems Announces Publication of New INTRACEPT Trial Data Demonstrating Long-Term Relief for Chronic Low Back Pain 24 Months Post-Procedure
30 nov. 2021 09h30 HE
|
Relievant Medsystems, Inc.
MINNEAPOLIS, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), today announced 24-month...